simendan has been researched along with Heart Valve Diseases in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (20.00) | 29.6817 |
| 2010's | 6 (60.00) | 24.3611 |
| 2020's | 2 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Li, H; Lv, X; Niu, Z; Qiao, H; Sheng, W; Wang, T; Wu, J; Zhang, W | 1 |
| Alvaro, G; Belletti, A; Boboshko, VA; Bove, T; Brazzi, L; Calabrò, MG; Comis, M; Frassoni, S; Grigoryev, EV; Guarracino, F; Lembo, R; Likhvantsev, VV; Lomivorotov, VV; Monaco, F; Navalesi, P; Pasyuga, VV; Paternoster, G; Pisano, A; Scandroglio, AM; Zangrillo, A | 1 |
| Gandham, R; Kaur, P; Kundra, TS; Manjunatha, N; Prabhakar, V | 1 |
| Alexander, JH; Anstrom, KJ; Argenziano, M; Cowper, PA; Duncan, AE; Fremes, S; Goodman, SG; Heringlake, M; Jankowich, R; Knight, JD; Leimberger, JD; Levy, JH; Lopes, RD; Luber, J; Mark, DB; Mehta, RH; Nagpal, AD; Teoh, K; Toller, W; van Diepen, S | 1 |
| Boysan, E; Cicekcioglu, F; Ersoy, O; Katircioglu, F; Unal, EU; Yay, K; Yener, U | 1 |
| Arya, VK; Dutta, V; Kumar, B; Mishra, A; Mishra, AK | 1 |
| Cicekcioglu, F; Ersoy, O; Hijazi, A; Katircioglu, SF; Parlar, AI; Yay, K | 1 |
| Kiviniemi, V; Lahtinen, P; Pitkänen, O; Pölönen, P; Turpeinen, A; Uusaro, A | 1 |
| Lehmann, A; Radke, J; Sack, FU | 1 |
| De Santis, V; Mazzesi, G; Miraldi, F; Ozdem, SS; Papalia, U; Puddu, PE; Tritapepe, L; Usta, C; Vitale, D | 1 |
6 trial(s) available for simendan and Heart Valve Diseases
| Article | Year |
|---|---|
Effect of Levosimendan on Renal Outcome in Cardiac Surgery Patients With Chronic Kidney Disease and Perioperative Cardiovascular Dysfunction: A Substudy of a Multicenter Randomized Trial.
Topics: Acute Kidney Injury; Aged; Brazil; Cardiac Surgical Procedures; Cardiotonic Agents; Dose-Response Relationship, Drug; Double-Blind Method; Female; Glomerular Filtration Rate; Heart Valve Diseases; Humans; Incidence; Italy; Male; Middle Aged; Mitral Valve; Perioperative Period; Postoperative Complications; Renal Insufficiency, Chronic; Russia; Simendan; Treatment Outcome | 2018 |
The Effect of Inhaled Milrinone Versus Inhaled Levosimendan in Pulmonary Hypertension Patients Undergoing Mitral Valve Surgery - A Pilot Randomized Double-Blind Study.
Topics: Administration, Inhalation; Adult; Blood Pressure; Cardiotonic Agents; Dose-Response Relationship, Drug; Double-Blind Method; Female; Follow-Up Studies; Heart Valve Diseases; Humans; Hypertension, Pulmonary; Male; Milrinone; Mitral Valve; Pilot Projects; Prospective Studies; Pulmonary Wedge Pressure; Simendan; Treatment Outcome; Vascular Resistance | 2018 |
Levosimendan in patients with reduced left ventricular function undergoing isolated coronary or valve surgery.
Topics: Aged; Cardiotonic Agents; Coronary Artery Bypass; Coronary Artery Disease; Cost-Benefit Analysis; Double-Blind Method; Drug Costs; Female; Heart Valve Diseases; Heart Valve Prosthesis Implantation; Hospital Costs; Humans; Male; Middle Aged; Postoperative Complications; Risk Assessment; Risk Factors; Simendan; Time Factors; Treatment Outcome; Ventricular Dysfunction, Left; Ventricular Function, Left | 2020 |
Effectiveness of prophylactic levosimendan in high-risk valve surgery patients.
Topics: Arterial Pressure; Cardiopulmonary Bypass; Cardiovascular Agents; Drug Administration Schedule; Familial Primary Pulmonary Hypertension; Heart Valve Diseases; Heart Valve Prosthesis Implantation; Hemodynamics; Humans; Hydrazones; Hypertension, Pulmonary; Infusions, Parenteral; Pulmonary Artery; Pyridazines; Severity of Illness Index; Simendan; Stroke Volume; Time Factors; Treatment Outcome; Turkey; Vascular Resistance | 2013 |
Comparative Effect of Levosimendan and Milrinone in Cardiac Surgery Patients With Pulmonary Hypertension and Left Ventricular Dysfunction.
Topics: Adult; Aortic Valve; Arterial Pressure; Drug Administration Schedule; Drug Therapy, Combination; Female; Heart Valve Diseases; Heart Valve Prosthesis Implantation; Humans; Hydrazones; Hypertension, Pulmonary; Male; Middle Aged; Milrinone; Mitral Valve; Norepinephrine; Postoperative Care; Prospective Studies; Pulmonary Artery; Pyridazines; Simendan; Vascular Resistance; Vasodilator Agents; Ventricular Dysfunction, Left | 2016 |
Levosimendan reduces heart failure after cardiac surgery: a prospective, randomized, placebo-controlled trial.
Topics: Aged; Cardiotonic Agents; Coronary Artery Bypass; Female; Heart Failure; Heart Valve Diseases; Hemodynamics; Humans; Hydrazones; Male; Middle Aged; Prospective Studies; Pyridazines; Simendan | 2011 |
4 other study(ies) available for simendan and Heart Valve Diseases
| Article | Year |
|---|---|
Prospective Study on the Postoperative Use of Levosimendan After Conventional Heart Valve Replacement.
Topics: Aged; Cardiotonic Agents; Female; Heart Valve Diseases; Heart Valve Prosthesis Implantation; Heart Valves; Humans; Length of Stay; Male; Postoperative Care; Postoperative Complications; Prospective Studies; Simendan | 2021 |
Levosimendan and severe pulmonary hypertension during open heart surgery.
Topics: Cardiac Surgical Procedures; Female; Follow-Up Studies; Heart Valve Diseases; Heart Valve Prosthesis Implantation; Humans; Hydrazones; Hypertension, Pulmonary; Middle Aged; Pyridazines; Simendan; Time Factors; Treatment Outcome; Vasodilator Agents | 2008 |
Levosimendan--an inoprotective drug or much ado about nothing?
Topics: Cardiotonic Agents; Coronary Artery Bypass; Female; Heart Failure; Heart Valve Diseases; Humans; Hydrazones; Male; Pyridazines; Simendan | 2011 |
Comparision of the inotropic effects of levosimendan, rolipram, and dobutamine on human atrial trabeculae.
Topics: Adult; Aged; Cardiotonic Agents; Coronary Artery Disease; Dobutamine; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Electric Stimulation; Female; Heart Atria; Heart Valve Diseases; Humans; Hydrazones; Male; Middle Aged; Myocardial Contraction; Pyridazines; Rheumatic Heart Disease; Rolipram; Simendan; Troponin C | 2004 |